CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

David Martin‐García(Centro de Investigación Biomédica en Red de Cáncer), Sı́lvia Beà(Centro de Investigación Biomédica en Red de Cáncer), Susanne Bens(Universität Ulm), Daphne de Jong(Amsterdam UMC Location Vrije Universiteit Amsterdam), Judith A. Ferry(The University of Texas MD Anderson Cancer Center), Fina Climent, Luis Veloza(Hospital Clínic de Barcelona), Steven H. Swerdlow(University of Pittsburgh), Dennis D. Weisenburger(University of Nebraska Medical Center), Eric D. Hsi(Cleveland Clinic), Andreas Rosenwald(National Institutes of Health), Elı́as Campo(Hospital Clínic de Barcelona), Leticia Quintanilla-Martı́nez(University of Tübingen), Reiner Siebert(Christian-Albrechts-Universität zu Kiel), Blanca González‐Farré(Hospital Clínic de Barcelona), Jesús Gutiérrez‐Abril(Universidad de Oviedo), Grzegorz Rymkiewicz(The Maria Sklodowska-Curie National Research Institute of Oncology), Blanca Espinet(Hospital Del Mar), Inmaculada Ribera‐Cortada(University of Andorra), Sergi Beltrán(Universitat de Barcelona), Renata Woroniecka, Dolors Costa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Itziar Salaverría(Christian-Albrechts-Universität zu Kiel), Laurence de Leval(University Hospital of Lausanne), German Ott, Sheila J.M. O’Connor(Leeds Teaching Hospitals NHS Trust), Estella Matutes(Institute of Cancer Research), Rafael Valdés‐Mas(Weizmann Institute of Science), Jan Delabie, Miriam Prieto(Centro de Investigación Biomédica en Red de Cáncer), David Torrents(Barcelona Supercomputing Center), Carlos López-Otı́n(Universidad de Oviedo), Elaine S. Jaffe(Center for Cancer Research), Xosé S. Puente(Universidad de Oviedo), Kai Fu(Tianjin Medical University Cancer Institute and Hospital), Alba Navarro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Guillem Clot(Aristotle University of Thessaloniki)
Blood
December 11, 2018
Cited by 112


Related Papers